Combining FAK inhibitors with low-dose radiation in pancreatic cancer can regulate the TME through several mechanisms, including reducing hypoxia, boosting immune cell infiltration, and enhancing radiosensitivity [160]. This evidence concerns the gene PTK2 and pancreatic neoplasm.